title: EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.
abstract: OBJECTIVE
  The systemic vasculitides are multiorgan diseases where early diagnosis and treatment can significantly improve outcomes. Robust nomenclature reduces diagnostic delay. However, key aspects of current nomenclature are widely perceived to be out of date, these include disease definitions, classification and diagnostic criteria. Therefore, the aim of the present work was to identify deficiencies and provide contemporary points to consider for the development of future definitions and criteria in systemic vasculitis.
  
  
  METHODS
  The expert panel identified areas of concern within existing definitions/criteria. Consequently, a systematic literature review was undertaken looking to address these deficiencies and produce 'points to consider' in accordance with standardised European League Against Rheumatism (EULAR) operating procedures. In the absence of evidence, expert consensus was used.
  
  
  RESULTS
  There was unanimous consensus for re-evaluating existing definitions and developing new criteria. A total of 17 points to consider were proposed, covering 6 main areas: biopsy, laboratory testing, diagnostic radiology, nosology, definitions and research agenda. Suggestions to improve and expand current definitions were described including the incorporation of anti-neutrophil cytoplasm antibody and aetiological factors, where known. The importance of biopsy in diagnosis and exclusion of mimics was highlighted, while equally emphasising its problems. Thus, the role of alternative diagnostic tools such as MRI, ultrasound and surrogate markers were also discussed. Finally, structures to develop future criteria were considered.
  
  
  CONCLUSIONS
  Limitations in current classification criteria and definitions for vasculitis have been identified and suggestions provided for improvement. Additionally it is proposed that, in combination with the updated evidence, these should form the basis of future attempts to develop and validate revised criteria and definitions of vasculitis.
authors.affiliation: University of Aberdeen, Aberdeen, UK.
authors.forename: Neil
authors.initials: N
authors.lastname: Basu
authors.forename: Richard
authors.initials: R
authors.lastname: Watts
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Bajema
authors.forename: Bo
authors.initials: B
authors.lastname: Baslund
authors.forename: Thorsten
authors.initials: T
authors.lastname: Bley
authors.forename: Maarten
authors.initials: M
authors.lastname: Boers
authors.forename: Paul
authors.initials: P
authors.lastname: Brogan
authors.forename: Len
authors.initials: L
authors.lastname: Calabrese
authors.forename: Maria C
authors.initials: MC
authors.lastname: Cid
authors.forename: Jan Willem
authors.initials: JW
authors.lastname: Cohen-Tervaert
authors.forename: Luis Felipe
authors.initials: LF
authors.lastname: Flores-Suarez
authors.forename: Shouichi
authors.initials: S
authors.lastname: Fujimoto
authors.forename: Kirsten
authors.initials: K
authors.lastname: de Groot
authors.forename: Loic
authors.initials: L
authors.lastname: Guillevin
authors.forename: Gulen
authors.initials: G
authors.lastname: Hatemi
authors.forename: Thomas
authors.initials: T
authors.lastname: Hauser
authors.forename: David
authors.initials: D
authors.lastname: Jayne
authors.forename: Charles
authors.initials: C
authors.lastname: Jennette
authors.forename: Cees G M
authors.initials: CG
authors.lastname: Kallenberg
authors.forename: Shigeto
authors.initials: S
authors.lastname: Kobayashi
authors.forename: Mark A
authors.initials: MA
authors.lastname: Little
authors.forename: Alfred
authors.initials: A
authors.lastname: Mahr
authors.forename: John
authors.initials: J
authors.lastname: McLaren
authors.forename: Peter A
authors.initials: PA
authors.lastname: Merkel
authors.forename: Seza
authors.initials: S
authors.lastname: Ozen
authors.forename: Xavier
authors.initials: X
authors.lastname: Puechal
authors.forename: Niels
authors.initials: N
authors.lastname: Rasmussen
authors.forename: Alan
authors.initials: A
authors.lastname: Salama
authors.forename: Carlo
authors.initials: C
authors.lastname: Salvarani
authors.forename: Caroline
authors.initials: C
authors.lastname: Savage
authors.forename: David G I
authors.initials: DG
authors.lastname: Scott
authors.forename: Mårten
authors.initials: M
authors.lastname: Segelmark
authors.forename: Ulrich
authors.initials: U
authors.lastname: Specks
authors.forename: Cord
authors.initials: C
authors.lastname: Sunderköetter
authors.forename: Kazuo
authors.initials: K
authors.lastname: Suzuki
authors.forename: Vladimir
authors.initials: V
authors.lastname: Tesar
authors.forename: Allan
authors.initials: A
authors.lastname: Wiik
authors.forename: Hasan
authors.initials: H
authors.lastname: Yazici
authors.forename: Raashid
authors.initials: R
authors.lastname: Luqmani
mesh_terms: D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D003697:Delphi Technique; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D056647:Systemic Vasculitis / Q000145:classification / Q000175:diagnosis*; D009626:Terminology as Topic
chemical_list: D015415:Biomarkers